Skip to main content
. 2022 Jun 17;4(2):zcac018. doi: 10.1093/narcan/zcac018

Table 3B.

Mayo-TNBC cohort: patient and immunological characteristics at initial diagnosis. It presents the immunological observations at initial diagnosis. Elevated lymphocytic activity was only marginally observed

Variable LAR Non-LAR
n = 50 n = 219 P value
Stromal TILs
Median 20% 25% 0.083
25th–75th percentile 10–40% 15–50%
Lymphocyte-dominant BC
Yes 8 (16.0%) 58 (26.7%) 0.145
No 42 (84.0%) 159 (73.3%)
Lymph node involvement
positive 22 (45.8%) 76 (35.2%) 0.188
negative 26 (54.2%) 50 (64.8%)
(not evaluated – NX) (2) (3)